Rxo (RXO) Net Cash Flow (2021 - 2026)

Rxo (RXO) has reported Net Cash Flow for 6 consecutive years, with -$6.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow fell 400.0% year-over-year to -$6.0 million; the trailing twelve-month figure through Jun 2026 stood at -$3.0 million (down 125.0% YoY), and the FY2025 full-year result was -$19.0 million, down 159.38% from the prior year.
• Net Cash Flow fell to -$6.0 million in Q2 2026 per RXO's latest filing, from $4.0 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $166.0 million in Q2 2022 and bottomed at -$100.0 million in Q4 2023.
• Historically, Net Cash Flow has averaged -$705882.4 across 5 years, with a median of $2.0 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow sank 8600.0% in 2022, then jumped 352.63% in 2024.
• Over 5 years, Net Cash Flow stood at -$87.0 million in 2022, then decreased by 14.94% to -$100.0 million in 2023, then soared by 82.0% to -$18.0 million in 2024, then jumped by 55.56% to -$8.0 million in 2025, then increased by 25.0% to -$6.0 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$6.0 million, $4.0 million, and -$8.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.